| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. | COO, GENERAL COUNSEL &CORP SEC | Common Stock | 32,699 | $23,543 | $0.7200 | 30 Jul 2021 | Direct |
| Eloxx Pharmaceuticals, Inc. | COO, GENERAL COUNSEL &CORP SEC | Restricted Stock Units | 9,375 | $6,750 | $0.7200 | 30 Jul 2021 | Direct |
| Acorda Therapeutics, Inc. | General Counsel and Corp Secy | Employee Stock Option (right to buy) | 77,300 | 31 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123022749-belloff-neil-s-2023-03-31 | Acorda Therapeutics, Inc. | 31 Mar 2023 | 1 | $0 | 4 | General Counsel and Corp Secy | 04 Apr 2023, 16:38 |
| /report/000120919121063723-belloff-neil-s-2021-11-08 | ACORDA THERAPEUTICS INC | 08 Nov 2021 | 1 | $0 | 4 | General Counsel | 09 Nov 2021, 18:03 |
| /report/000120919121063716-belloff-neil-s-2021-11-08 | ACORDA THERAPEUTICS INC | 08 Nov 2021 | 0 | $0 | 3 | General Counsel | 09 Nov 2021, 17:58 |
| /report/000141588921003750-belloff-neil-s-2021-07-30 | Eloxx Pharmaceuticals, Inc. | 30 Jul 2021 | 3 | -$606 | 4 | COO, GENERAL COUNSEL &CORP SEC | 30 Jul 2021, 20:32 |
| /report/000141588921002682-belloff-neil-s-2021-05-25 | Eloxx Pharmaceuticals, Inc. | 25 May 2021 | 3 | -$2,551 | 4 | COO, GENERAL COUNSEL &CORP SEC | 26 May 2021, 16:10 |